These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23775746)

  • 1. A flow cytometric crossmatch test using endothelial precursor cells isolated from peripheral blood.
    Jackson AM; Lucas DP; Badders JL
    Methods Mol Biol; 2013; 1034():319-29. PubMed ID: 23775746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A flow cytometric crossmatch test for simultaneous detection of antibodies against donor lymphocytes and endothelial precursor cells.
    Alheim M; Johansson SM; Hauzenberger D; Grufman P; Holgersson J
    Tissue Antigens; 2010 Mar; 75(3):269-77. PubMed ID: 20070600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.
    AlMahri A; Holgersson J; Alheim M
    Tissue Antigens; 2012 Nov; 80(5):404-15. PubMed ID: 22931381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical cytometry and progress in HLA antibody detection.
    Bray RA; Tarsitani C; Gebel HM; Lee JH
    Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte crossmatching by flow cytometry.
    Bray RA
    Methods Mol Biol; 2013; 1034():285-96. PubMed ID: 23775742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-dependent cytotoxicity crossmatch.
    Peña JR; Fitzpatrick D; Saidman SL
    Methods Mol Biol; 2013; 1034():257-83. PubMed ID: 23775741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the virtual crossmatch in solid organ transplantation.
    Amico P; Hönger G; Steiger J; Schaub S
    Curr Opin Organ Transplant; 2009 Dec; 14(6):656-61. PubMed ID: 19741534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of flow cytometry to define unacceptable HLA antigens in lung transplant recipients with HLA-specific antibodies.
    Appel JZ; Hartwig MG; Cantu E; Palmer SM; Reinsmoen NL; Davis RD
    Transplantation; 2006 Apr; 81(7):1049-57. PubMed ID: 16612283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective disappearance of donor-specific antibodies and absence of acute rejection after liver transplantation in a patient with a strongly positive lymphocyte crossmatch.
    Bastani B
    Arch Iran Med; 2006 Apr; 9(2):163-4. PubMed ID: 16649363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q assay for the detection of complement fixing antibody to HLA antigens.
    Chen G; Tyan DB
    Methods Mol Biol; 2013; 1034():305-11. PubMed ID: 23775744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
    Delgado JC; Eckels DD
    Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid phase assay measuring C4d deposition to determine complement fixation by HLA-specific antibodies.
    Smith JD; Rose ML
    Methods Mol Biol; 2013; 1034():297-303. PubMed ID: 23775743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
    Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ
    Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved flow cytometry based cytotoxicity and binding assay for clinical antibody HLA crossmatching.
    Alheim M; Paul PK; Hauzenberger DM; Wikström AC
    Hum Immunol; 2015 Nov; 76(11):849-57. PubMed ID: 26429307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
    Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of the endothelial precursor cell crossmatch test in lymphocyte crossmatch positive and negative patients evaluated for living donor kidney transplantation.
    Alheim M; AlMahri A; Nilsson J; Tydén G; Holgersson J
    Hum Immunol; 2013 Nov; 74(11):1437-44. PubMed ID: 23777925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.